EarlyCDT® is a registered trademark of Oncimmune. Used with permission. 89041-8
LOINC Code
| LOINC code | 89041-8 | ||
|---|---|---|---|
| name | EarlyCDT® is a registered trademark of Oncimmune. Used with permission. | ||
| description | Screening for lung cancer using computerized tomography (CT) has been shown to decrease mortality by 20%. CT is an expensive procedure that also can reveal non-malignant changes on the chest CT. The EarlyCDT-Lung assay is a cheaper alternative with fairly good sensitivity and specificity for detecting early, asymptomatic non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). To achieve the desired specificity of 90%, the autoantibody cutoff values were chosen based on that goal. The overall sensitivity/specificity of the assay was determined to be 38%/88%. When the sensitivity and specificity were measured based on the type of tumor, NSCLC was 34%/88% and SCLC was 50%/88%.[http://cancerpreventionresearch.aacrjournals.org/content/4/7/1126.long#ref-1] | ||
| status | ACTIVE | ||
Fully-Specified Name | |||
| component | Lung cancer antibody | ||
| property | Imp = Impression/interpretation of study | ||
| time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
| system | Ser/Plas Ser = Serum Plas = Plasma | ||
| scale | Nom = Nominal: Nominal or categorical responses that do not have a natural ordering. (e.g., names of bacteria, reported as answers, categories of appearance that do not have a natural ordering, such as, yellow, clear, bloody. | ||
| method | IA = Immunoassay: Encompasses all immunoassays with a few exceptions, including Immune Blot and Immune Fluorescence, which were created based on historic usage. | ||
Additional Names | |||
| short name | Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lung cancer Ab; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or pla | ||
Basic Attributes | |||
| class | SERO | ||
| type | 1 Laboratory | ||
| order vs. observation | Lung cancer ant | ||
Member of these Panels | |||
| |||
History/Usage | |||
| first released | EarlyCDT_Oncimmune | ||
| last updated | 2.73 | ||
| last change type | MIN - change to field other than name | ||
Related Names | |||
Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com